From 1999 through 2001, two of the 175 patients on whom Isom performed a simple coronary artery bypass graft (CABG) died, a 1.14 percent mortality rate, according to figures recently released by the New York State Department of Health.

CNN: Heart surgeon meets tee time, misses Clinton

To get close to profitability, Price is also betting on Neutralase, a drug that would be used in coronary-artery bypass graft operations--more commonly referred to as open-heart surgery.

FORBES: BioMarin Gets Ready To Bloom